Literature DB >> 19275669

Connexins, diabetes and the metabolic syndrome.

Romain Hamelin1, Florent Allagnat, Jacques-Antoine Haefliger, Paolo Meda.   

Abstract

Diabetes and the related metabolic syndrome are multi system disorders that result from improper interactions between various cell types. Even though the underlying mechanism remains to be fully understood, it is most likely that both the long and the short distance range cell interactions, which normally ensure the physiologic functioning of the pancreas, and its relationships with the insulin-targeted organs, are altered. This review focuses on the short-range type of interactions that depend on the contact between adjacent cells and, specifically, on the interactions that are dependent on connexins. The widespread distribution of these membrane proteins, their multiple modes of action, and their interactions with conditions/molecules associated to both the pathogenesis and the treatment of the 2 main forms of diabetes and the metabolic syndrome, make connexins an essential part of the chain of events that leads to metabolic diseases. Here, we review the present state of knowledge about the molecular and cell biology of the connexin genes and proteins, their general mechanisms of action, the roles specific connexin species play in the endocrine pancreas and the major insulin-targeted organs, under physiological and patho-physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275669     DOI: 10.2174/138920309787315167

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  16 in total

Review 1.  Connexins and the kidney.

Authors:  Fiona Hanner; Charlotte Mehlin Sorensen; Niels-Henrik Holstein-Rathlou; János Peti-Peterdi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-17       Impact factor: 3.619

Review 2.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 3.  Connexin channel and its role in diabetic retinopathy.

Authors:  Sayon Roy; Jean X Jiang; An-Fei Li; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2017-06-08       Impact factor: 21.198

Review 4.  New insights into the role of connexins in pancreatic islet function and diabetes.

Authors:  Nikki L Farnsworth; Richard K P Benninger
Journal:  FEBS Lett       Date:  2014-02-28       Impact factor: 4.124

5.  Phase transitions in pancreatic islet cellular networks and implications for type-1 diabetes.

Authors:  I J Stamper; Elais Jackson; Xujing Wang
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2014-01-27

6.  Effects of vitamin D receptor knockout on cornea epithelium gap junctions.

Authors:  Xiaowen Lu; Mitchell A Watsky
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-06       Impact factor: 4.799

7.  Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression.

Authors:  Véronique Serre-Beinier; Domenico Bosco; Laurence Zulianello; Anne Charollais; Dorothée Caille; Eric Charpantier; Benoit R Gauthier; Giuseppe R Diaferia; Ben N Giepmans; Roberto Lupi; Piero Marchetti; Shaoping Deng; Léo Buhler; Thierry Berney; Vincenzo Cirulli; Paolo Meda
Journal:  Hum Mol Genet       Date:  2008-11-10       Impact factor: 6.150

8.  Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse.

Authors:  W Steven Head; Meredith L Orseth; Craig S Nunemaker; Leslie S Satin; David W Piston; Richard K P Benninger
Journal:  Diabetes       Date:  2012-04-17       Impact factor: 9.461

9.  Connexins and diabetes.

Authors:  Josephine A Wright; Toby Richards; David L Becker
Journal:  Cardiol Res Pract       Date:  2012-03-01       Impact factor: 1.866

10.  Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles.

Authors:  Jacques-Antoine Haefliger; David Martin; Dimitri Favre; Yannick Petremand; Lucia Mazzolai; Amar Abderrahmani; Paolo Meda; Gérard Waeber; Florent Allagnat
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.